7th Immunotherapy of Cancer Conference

Save The Date!

Welcome to the seventh edition of the Immunotherapy of Cancer Conference (ITOC7), the premier annual meeting for education, scientific exchange and networking within cancer immunotherapy.
October 3 -5, 2020 | Munich, Germany

The Immunotherapy of Cancer Conference (ITOC – www.itoc-conference.eu) is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.

ITOC7 is organised by the Tumor Centre in Munich (TZM) as well as the Ludwig Maximilians University (LMU) in Munich. The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery. We are addressing experts from academia, pharmaceutical industry, regulatory authorities and patient advocates.

The program will focus on the latest challenges of translational research with a special emphasis on innovations in combination therapy, immuno-monitoring, and biomarker development.

Sign Up Now
The deadline for pre-registration is September 14, 2020

Submit Now
Submit your abstract until June 30, 2020 to present your work at ITOC7

 

Cooperation Partners